A detailed history of Prudent Man Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Prudent Man Advisors, LLC holds 877 shares of LLY stock, worth $896,030. This represents 0.25% of its overall portfolio holdings.

Number of Shares
877
Previous 985 10.96%
Holding current value
$896,030
Previous $767,000 12.78%
% of portfolio
0.25%
Previous 0.25%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

SELL
$625.65 - $812.69 $67,570 - $87,770
-108 Reduced 10.96%
877 $669,000
Q2 2025

Jul 31, 2025

BUY
$713.71 - $898.95 $154,875 - $195,072
217 Added 28.26%
985 $767,000
Q1 2025

May 01, 2025

BUY
$725.72 - $929.72 $66,040 - $84,604
91 Added 13.44%
768 $634,000
Q4 2024

Feb 05, 2025

BUY
$727.2 - $932.06 $265,428 - $340,201
365 Added 116.99%
677 $522,000
Q3 2024

Nov 07, 2024

BUY
$772.14 - $960.02 $240,907 - $299,526
312 New
312 $276,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $971B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Prudent Man Advisors, LLC Portfolio

Follow Prudent Man Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudent Man Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prudent Man Advisors, LLC with notifications on news.